536 related articles for article (PubMed ID: 19183379)
1. Mutant p53 and cyclin A1 protein expression in primary laryngeal squamous cell carcinomas do not correlate to second primary tumours of the head and neck.
Farhadieh RD; Smee R; Rees CG; Salardini A; Eggleton S; Yang JL; Russell PJ
ANZ J Surg; 2009; 79(1-2):48-54. PubMed ID: 19183379
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
4. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.
Tokumaru Y; Yamashita K; Osada M; Nomoto S; Sun DI; Xiao Y; Hoque MO; Westra WH; Califano JA; Sidransky D
Cancer Res; 2004 Sep; 64(17):5982-7. PubMed ID: 15342377
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
6. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
7. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
[TBL] [Abstract][Full Text] [Related]
8. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
9. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
Waitzberg AF; Nonogaki S; Nishimoto IN; Kowalski LP; Miguel RE; Brentani RR; Brentani MM
Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897
[TBL] [Abstract][Full Text] [Related]
11. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
[TBL] [Abstract][Full Text] [Related]
12. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the expression of cyclin A protein and p53 activity in oral squamous cell carcinomas.
Chen Q; Zhou H; Guo W; Samaranayake LP; Zhou M; Li B
Cytobios; 2001; 106(412):87-99. PubMed ID: 11503976
[TBL] [Abstract][Full Text] [Related]
15. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.
Takes RP; Baatenburg de Jong RJ; Schuuring E; Litvinov SV; Hermans J; Van Krieken JH
Anticancer Res; 1998; 18(6B):4793-800. PubMed ID: 9891559
[TBL] [Abstract][Full Text] [Related]
16. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between expression of p53 and prognosis of laryngeal squamous carcinoma].
Xia LP; Zeng ZY; Guo ZM; Rao HL; Zeng J; Xu GP; Zhang Q
Ai Zheng; 2003 Jan; 22(1):77-82. PubMed ID: 12561442
[TBL] [Abstract][Full Text] [Related]
18. p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
Henriksson E; Baldetorp B; Borg A; Kjellen E; Akervall J; Wennerberg J; Wahlberg P
Acta Oncol; 2006; 45(3):300-5. PubMed ID: 16644573
[TBL] [Abstract][Full Text] [Related]
19. Loss of retinoblastoma protein expression in laryngeal squamous cell carcinoma.
Mizokami H; Sawatsubashi M; Tokunaga O; Shin T
Mod Pathol; 1999 Jan; 12(1):47-53. PubMed ID: 9950162
[TBL] [Abstract][Full Text] [Related]
20. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
